CD274 and non-small cell lung carcinoma: Kim et al. recruited a total of 84 NSCLC patients to evaluate the importance of MYC, and their study showed that patients with expression of both MYC and PD-L1 had a poorer disease-free survival (7.1 vs 31.1 months, P-value: 0.011) than patients without double-positive expression pattern [65].